NEW YORK, August 22, 2018 /PRNewswire/ -- This report analyzes the worldwide markets for Artificial Tears in US$ Thousand.
Read the full report: https://www.reportlinker.com/p0960376
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 49 companies including many key and niche players such as:
- Allergan, Inc.
- Akorn, Inc.
- Bausch & Lomb Incorporated
- Johnson & Johnson
- Novartis International AG
- Santen Pharmaceuticals Co, Ltd.
Read the full report: https://www.reportlinker.com/p0960376
ARTIFICIAL TEARS MCP-7
A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
2. INDUSTRY OVERVIEW
Dry Eyes - A Lucrative Segment of Ophthalmology Market
Table 1: Global Ophthalmology Market (2017): Percentage Share Breakdown by Product Segment (includes corresponding Graph/Chart)
Artificial Tears: The First Line and Mainstay Treatment for Dry Eyes
Table 2: Global Dry Eye Treatment Market (2017): Percentage Share Breakdown of Revenues by Over-the-Counter and Rx Segments (includes corresponding Graph/Chart)
Other Therapies for Dry Eye
Current & Future Analysis
Developing Countries Display Strong Growth Prospects
Under-reporting of DES Condition Stifles Market Opportunities
Prevalence and Incidence of Dry Eye Syndrome
Table 3: Prevalence of Dry Eye Syndrome Across Select Countries (in %) (includes corresponding Graph/Chart)
Select Stats on Prevalence Rates
Concentrated Prescription Dry Eye Products Market Benefits OTC Market
Multi-Factorial Nature of Dry Eye Poses Challenges to Drug Makers
Aging Population - A Major Growth Driver
Table 4: Global Population Demographics (2017 & 2020P): Percentage Breakdown of Population by Age Group - Below
Years and 40 Years & Above (includes corresponding Graph/Chart)
Market Challenges
Lack of Clear Product Differentiation
Drug Formulation Fraught with Difficulties
Low Patient Compliance Limits Market Opportunities
3. NOTEWORTHY MARKET TRENDS
Companies Focus on New Formulations to Improve Results
Preference for Preservative-Free Artificial Tears on Rise
Management of Dry Eyes Post Eye Surgery Drives Demand for Artificial Tears
Table 5: Number of LASIK Surgeries in US and Europe (2015-2020) (in '000) (includes corresponding Graph/Chart)
Rise in Mobile Workforce and Number of Smartphone Addicts Spurs Growth Prospects
Table 6: Global Smartphone Adoption Rate (2013-2020) (includes corresponding Graph/Chart)
Table 7: Number of Mobile Phone Users Worldwide (2014-2020) (in Billions) (includes corresponding Graph/Chart)
An Upswing in Contact Lens Wearers Unfolds New Opportunities
Table 8: Penetration of Contact Lenses in Select Countries/Regions (2017) (includes corresponding Graph/Chart)
Manufacturers Focus Efforts on Formulating the Right Artificial Tears for Contact Lens Wearers
Environmental Factors Play an Important Role
Nanotechnology and Other Innovative Delivery Techniques Gain Attention in DES Treatment
Direct-to-Customer Promotions: A Primary Marketing Strategy
4. DRY EYE SYNDROME - AN OVERVIEW
Dry Eye - A Common Ophthalmic Condition
Causes of Dry Eyes
Diagnosis of Dry Eye Syndrome
Multi-Factorial Nature of Dry Eye Poses Challenge to Drug Makers
Bridging Chasm between Diagnosis and Treatment of Dry Eye Syndrome
Product Options for Dry Eye Syndrome: Breakdown by Palliative Therapies and Targeted Therapies
KCS Inflammation Cycle
Common Symptoms of KCS
Risk Factors for Dry Eye Disease
Impact of Dry Eye Syndrome on Routine Daily Life Activities: Ranking based on Intensity of Impact Felt by Patients
Novel Approaches to Revolutionize Dry Eye Therapy
Anti-Inflammatory Drugs
Mucin Secretagogues
Hormonal Therapies
Omega-3 Drugs
Muco-Mimetics
Barrier-function Drugs
5. PRODUCT OVERVIEW
Artificial Tears - An Overview
Types of Artificial Tears
Artificial Tears Usage and Dosage
Evolution of Artificial Tears
First-Generation
Second-Generation
Third-Generation
Fourth-Generation
Alternate Treatment Methods
6. COMPETITIVE LANDSCAPE
Leading Players
Table 9: Leading Players in the Global Artificial Tears Market (2016): Percentage Share Breakdown of Sales by Company (includes corresponding Graph/Chart)
Artificial Tears for Dry Eye Syndrome-Single-use (Unit dose)
Artificial Tears for Dry Eye Syndrome-Multi dose
6.1 Focus on Select Global Players
Allergan plc (Ireland)
Akorn, Inc. (USA)
Bausch & Lomb Incorporated (USA)
Johnson & Johnson (USA)
Novartis International AG (Switzerland)
Alcon, Inc. (Switzerland)
Santen Pharmaceuticals Co, Ltd. (Japan)
6.2 Product Launches/Approvals/Introductions
Alcon Launches Systane Complete
Grafton Optical Adds I-LID 'N LASH® Ocular Hygiene Product Line from I-MED Pharma
Allergan Introduces TrueTear (Allergan)
Novaliq Introduces NovaTears®
Allergan Launches REFRESH OPTIVE® MEGA-3
Thea Pharmaceuticals Introduces Thealoz Duo
6.3 Recent Industry Activity
Novartis to Spinoff Alcon
I-MED Pharma Signs Distribution Agreement with IMEX
Novartis to In-license ECF843 for Ophthalmic Indications
Johnson & Johnson Acquires Abbott Medical Optics
7. GLOBAL MARKET PERSPECTIVE
Table 10: World Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2
(includes corresponding Graph/Chart)
Table 11: World Historic Review for Artificial Tears by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
Table 12: World 14-Year Perspective for Artificial Tears by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
8. REGIONAL MARKET PERSPECTIVE
8.1 The United States
A.Market Analysis
Current and Future Analysis
Table 13: Prevalence of Dry Eye Disease in the US (2017): Percentage Breakdown by Dry Eye Category (includes corresponding Graph/Chart)
Demographics Remain an Important Growth Driver
Table 14: US Population Demographics (2015-2030): Percentage Breakdown of Population by Age Group (includes corresponding Graph/Chart)
Table 15: Prevalence of Dry Eye Condition in the US (2014) (includes corresponding Graph/Chart)
Table 16: US Women Population (2015-2030): Percentage Breakdown of Population by Age Group (includes corresponding Graph/Chart)
Lifestyle and Environmental Factors - A Major Reason Behind Rise in Eye Care Market
Air Pollution Bears Close Association with DES Risk
B.Market Analytics
Table 17: US Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
Table 18: US Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
8.2 Canada
Market Analysis
Table 19: Canadian Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2
(includes corresponding Graph/Chart)
Table 20: Canadian Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
8.3 Japan
A.Market Analysis
Current and Future Analysis
B.Market Analytics
Table 21: Japanese Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2
(includes corresponding Graph/Chart)
Table 22: Japanese Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
8.4 Europe
A.Market Analysis
Current and Future Analysis
Market Overview
Overview of Select Markets
Germany
Italy
UK
Russia
B.Market Analytics
Table 23: European Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
Table 24: European Historic Review for Artificial Tears by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
Table 25: European 14-Year Perspective for Artificial Tears by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2011, 2018 & 2
(includes corresponding Graph/Chart)
8.5 Asia-Pacific
A.Market Analysis
Current and Future Analysis
Focus on Select Regional Markets
Australia
China
India
B.Market Analytics
Table 26: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
Table 27: Asia-Pacific Historic Review for Artificial Tears by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2
(includes corresponding Graph/Chart)
Table 28: Asia-Pacific 14-Year Perspective for Artificial Tears by Geographic Region/Country - Percentage Breakdown of Dollar Sales for China, India, and Rest of Asia-Pacific Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
8.6 Latin America
A.Market Analysis
Current and Future Analysis
B.Market Analytics
Table 29: Latin American Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2
(includes corresponding Graph/Chart)
Table 30: Latin American Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
8.7 Rest of World
Market Analysis
Table 31: Rest of World Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2
(includes corresponding Graph/Chart)
Table 32: Rest of World Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
9. COMPANY PROFILES
Total Companies Profiled: 49 (including Divisions/Subsidiaries - 54) The United States (19) Canada (3) Japan (3) Europe (14) - France (1) - Germany (3) - The United Kingdom (3) - Italy (1) - Spain (1) - Rest of Europe (9) Asia-Pacific (Excluding Japan) (12) Middle East (1) Africa (2)
Read the full report: https://www.reportlinker.com/p0960376
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article